Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy
Niels Rahe‐Meyer(Francis Hospital), Ranjodh Gill, Radim Brát(University of Ostrava), A. A. Klein(Papworth Hospital NHS Foundation Trust), C. David Mazer(St. Michael's Hospital), Ramakrishnan Ranganath(CSL (United States)), Alexey Schramko(University of Helsinki), Jerrold H. Levy(Duke University), Yuki UEDA(Nagoya University), Dirk S. Schmidt(Behringwerke (Germany)), Yutaka Okita(Takatsuki General Hospital)
Cited by 152
Related Papers
Guidelines for Perioperative Care in Cardiac Surgery
|JAMA Surgery|2019|1.2k
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
|New England Journal of Medicine|2017|1.1k
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711
Patient Blood Management
|JAMA|2019|619
Effects of Red-Cell Storage Duration on Patients Undergoing Cardiac Surgery
|New England Journal of Medicine|2015|489